Advertisement

Topics

FDA approves Ultragenyx drug for rare enzyme disorder

07:36 EST 15 Nov 2017 | Reuters

(Reuters) - The U.S. Food and Drug Administration approved on Wednesday a new treatment made by Ultragenyx Pharmaceutical Inc for a rare genetic disorder that can dramatically reduce life expectancy.

Original Article: FDA approves Ultragenyx drug for rare enzyme disorder

NEXT ARTICLE

More From BioPortfolio on "FDA approves Ultragenyx drug for rare enzyme disorder"

Advertisement
Quick Search
Advertisement
Advertisement